TFS CAPITAL LLC - JUNIPER PHARMACEUTICALS INC ownership

JUNIPER PHARMACEUTICALS INC's ticker is JNP and the CUSIP is 48203L107. A total of 39 filers reported holding JUNIPER PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of JUNIPER PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$83,000
-44.7%
16,490
-47.8%
0.03%
-32.7%
Q1 2017$150,000
+57.9%
31,619
+87.0%
0.05%
+96.0%
Q4 2016$95,000
+15.9%
16,912
+15.0%
0.02%
+25.0%
Q3 2016$82,000
-77.0%
14,707
-57.5%
0.02%
-47.4%
Q4 2015$356,000
-69.7%
34,611
-65.3%
0.04%
-66.4%
Q3 2015$1,176,00099,8230.11%
Other shareholders
JUNIPER PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 388,132$1,844,0000.38%
Krensavage Asset Management, LLC 243,128$1,155,0000.37%
ALGERT GLOBAL LLC 108,315$514,0000.14%
HEARTLAND ADVISORS INC 400,000$1,900,0000.12%
AWM Investment Company, Inc. 200,000$950,0000.09%
TFS CAPITAL LLC 31,619$150,0000.05%
GLOBEFLEX CAPITAL L P 20,012$95,0000.02%
Spark Investment Management LLC 45,100$214,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,200$856,0000.01%
Acrospire Investment Management LLC 1,605$8,0000.01%
View complete list of JUNIPER PHARMACEUTICALS INC shareholders